Announced
Completed
Synopsis
Archimed, a pan-European private equity healthcare specialist, made a €70m bid for Bomi Italia, a medtech and pharma services provider. The bid for Bomi Group, listed on Borsa Italia’s AIM market translates into a per share offer of €4.00 (30.67% above last official closing price of €3.06 and 50.38% above the six-month average price of €2.66). “In addition to its sector expertise and industry networks, ArchiMed intends to make significant investments, allowing Bomi Group to expand more rapidly, both organically and through acquisitions. The entry of such a strong and specialized stakeholder represents clear added value when it comes to the fulfilment of our ambitious growth targets,” says Bomi Group Chief Executive Marco Ruini.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.